Navigation Links
Cancer Diagnostics Universe Discussed in Comprehensive VPG Research Study Published at MarketPublishers.com
Date:8/6/2014

London, UK (PRWEB) August 06, 2014

The market for cancer diagnostics is on the verge of exploding, as the research workers approach key technology advances relating to tumour diagnosis and treatment, discover novel tumour-specific antigens, and also get to the heart of the mystery of the genetic basis of this insidious disease. Over the next five years, the global cancer diagnostics marketplace promises to be a very dynamic and rapidly expanding sphere. Expected advancements in technology will create multiple opportunities for determining genetic susceptibility, identifying specific tumours, and investigating the human body's biological response to cancer therapy and treatment. Furthermore, the upsurge in the ageing human population is anticipated to compound the soaring demand for malignancy assays and the fast-paced market expansion from pole to pole.

Comprehensive study “2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations” prepared by Venture Planning Group (VPG) is now available at MarketPublishers.com.

Report Details:

Title: 2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
Published: July, 2014
Pages: 1200
Price: US$ 34,500.00
http://marketpublishers.com/report/diagnostics-diseases/cancer/2014-market-segmentation-analysis-of-global-cancer-diagnostics-industry.html

The research report provides a strategic analysis of key business opportunities in the cancer diagnostics market globally with a focus on the 7 key countries (France, Germany, Italy, Japan, Spain, the UK, and the USA) in the forthcoming years. The report examines trends in the regions covered; reviews current and emerging assays; analyses potential applications of innovative diagnostic technologies; covers sales and market shares of leading suppliers of cancer diagnostic products (by test and country); presents sales and test volume forecasts of leading tumor markers by market segment and country; profiles the dominant players along with potential entrants into the market. A variety of business expansion strategies for suppliers are identified in the research study as well.

Report Scope:

  •         Overview of the global tumour diagnostics market, including 5-year test volume and sales projections by country; market segmentation analysis; the estimated number of laboratories performing respective testing (by country); tumour statistics, etiology and latest developments region-wise.
  •         Up-close look at the opportunities arising including appropriate strategic recommendations.
  •         Thorough study of more than 200 cancer diagnostic tests, current and emerging.
  •     Suppliers’ shares and market shares (by test and country); 5-year test volume and sales forecast data for key tumour markers (by country and market segment).
  •     Comprehensive assessment of instrumentation for cancer testing.
  •     Assessment of modern technologies (including complementing/ competing ones) and their potential applications for cancer diagnostic testing; extensive listings of organisations developing novel tumour diagnostic tests and detection technologies.    
  •         Strategic evaluations of the top suppliers and start-ups that develop new cancer diagnostic products and technologies.

More comprehensive and new market research reports by the publisher can be found at VPG page.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12075850.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. New Stool Test Might Aid in Early Detection of Colon Cancer
3. Study reveals how cancer drug causes diabetic-like state
4. How a cancer drug leads to diabetes
5. You Survived Cancer: Now Pay Attention to Your Overall Health
6. New drug prevents spread of human prostate cancer cells
7. Eliminating the good cholesterol receptor may fight breast cancer
8. Taller, Heavier Women May Face Higher Ovarian Cancer Risk
9. Experimental Chemo Combo for Colon Cancer Disappoints
10. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
11. Targeted therapeutics for colon cancer to be presented at AACR meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/26/2016)... ... 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to ... app. The fitness app plans to fix the two major problems leading the fitness industry ... fits all type program , They don’t eliminate all the reasons people quit ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
(Date:6/23/2016)... , June 23, 2016 ... Oticon , industry leaders in advanced ... launch of Oticon Opn ™, the world,s first ... of possibilities for IoT devices.      (Photo: ... Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology: